Cleo Diagnostics Ltd (cov) Logo

Cleo Diagnostics Ltd (COV)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials

COV ASX Chart

Snapshot

Cleo Diagnostics Limited (COV) (Cleo, or the Company) is bringing to market a simple blood test for the accurate and early diagnosis of ovarian cancer, using its novel patented CXCL10 biomarker. Cleo's first test - AdnexaSureTM is designed to distinguish benign from malignant growths and will be compatible with standard diagnostic laboratory workflows worldwide.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) +88.49%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,374 of 2,357
Sector Rank 130 of 230

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies ECS / CAN / CTE
EPS -$0.032
DPS $0.00
Book Value Per Share $0.07

Broker Consensus

COV is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Melbourne VIC 3000
Website www.cleodx.com
Registry Xcend
Auditor BDO Audit Pty Ltd
Date Listed 22 Aug 2023

Upcoming Calendar (Forecasted)

Date Event
27/02/2025 Report (Interim)
26/08/2025 Report (Prelim)
26/08/2025 Report (Annual)
27/08/2025 Report (Prelim)

Former Company Names

  • Cleo Diagnostics Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Interests

The current holdings of COV directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Andrew Stephens 27/08/2024 N/A 500,000 1,500,000 N/A
Lucinda Nolan 27/08/2024 N/A N/A 1,500,000 N/A
Richard Allman 27/08/2024 1,500,000 N/A 2,500,000 N/A
Thomas Jobling 27/08/2024 1,000,000 250,000 1,500,000 N/A
Adrien Wing 27/08/2024 N/A 14,250,000 N/A N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Jul 31, 2024.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Hudson Institute Investment Holdings Pty Ltd 7,500,000 5.84%
Loumea Investment Pty Ltd 7,000,000 5.45%
Michelle Wing 6,500,000 5.06%
Wing Investment Holdings Pty Ltd <Wing Family A/C> i 6,500,000 5.06%
Zen Innovations Pty Ltd 3,000,000 2.33%
Natalie Patterson 3,000,000 2.33%
Hardy Road Investments Pty Ltd 2,130,000 1.66%
Clinton Carey 2,125,000 1.65%
Jawaf Enterprises Pty Ltd <Hall Family A/C> 2,000,000 1.56%
Eduardo Vom 2,000,000 1.56%
DC & PC Holdings Pty Ltd <Dc & Pc Neesham Super A/C> 1,700,000 1.32%
Citicorp Nominees Pty Limited 1,538,414 1.20%
Ogg Pty Ltd 1,500,000 1.17%
Richard Allman 1,500,000 1.17%
Richard Vom 1,500,000 1.17%
Wing Investment Holdings Pty Ltd <Wing Family A/C> ii 1,250,000 0.97%
Apnea Holdings Pty Ltd <Kelly Family A/C> 1,200,000 0.93%
Brett Wing 1,200,000 0.93%
Kevin Frederick Wellisch 1,125,000 0.88%
Thomas William Jobling 1,000,000 0.78%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 15 217 127 412 197 968

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Hudson Institute Investment Holdings Pty Ltd 31/07/2024 7,500,000 5.84
Richard Vom 31/07/2024 9,515,000 7.41
Michelle Wing 31/07/2024 14,250,000 11.09

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2024 $0.34 28 June
COV Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.